Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 50 IN PLASTIC CONTAINER versus DEXTROSE 60 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 50 IN PLASTIC CONTAINER versus DEXTROSE 60 IN PLASTIC CONTAINER.
DEXTROSE 50% IN PLASTIC CONTAINER vs DEXTROSE 60% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose is a monosaccharide that serves as a source of energy for the body. It is rapidly metabolized to produce glucose, which is essential for cellular metabolism. Intravenous administration increases blood glucose levels, providing calories and correcting hypoglycemia.
Dextrose 60% is a hypertonic solution that increases blood glucose levels, providing a source of calories and fluid. It acts as an osmotic diuretic at high concentrations, drawing water from intracellular to extracellular spaces.
Intravenous administration of 25 g (50 mL of 50% solution) for hypoglycemia; may repeat as needed. For hyperkalemia, administer 25 g (50 mL) with 10 units of regular insulin intravenously. Continuous infusion for parenteral nutrition is 5-25 g per liter of total nutrient admixture, rate based on glucose tolerance.
250 mL of 60% dextrose (150 g) intravenously over 2 hours for hypoglycemia; for parenteral nutrition, dosage individualized based on caloric requirements and glucose tolerance.
None Documented
None Documented
Terminal elimination half-life of glucose is approximately 1.5-2 hours in normoglycemic individuals; prolonged in renal or hepatic impairment or hyperglycemic states.
Approximately 1.5-2.5 hours for exogenous glucose; clinically relevant in monitoring glucose infusion rates in critically ill patients.
Excreted primarily via renal routes: ~10% unchanged in urine; remainder metabolized to carbon dioxide and water, exhaled via lungs. Fecal elimination negligible.
Renal: essentially 100% as CO2 and water; negligible unchanged glucose under normal conditions; in hyperglycemia, small amounts (<5%) excreted unchanged in urine when renal threshold exceeded.
Category C
Category C
Intravenous Hypertonic Dextrose Solution
Intravenous Hypertonic Dextrose Solution